Effects of Cilazapril on atrial electrical, structural and functional remodeling in atrial fibrillation dogs

Journal of Electrocardiology

Volumn 40, Issue 1, 2007, Pages 100.e1-100.e6

  Li, Yue ^a   Li, Weimin ^a   Yang, Baofeng ^a   Han, Wei ^a   Dong, Deli ^a   Xue, Jingyi ^a   Li, Baoxin ^a   Yang, Shusen ^a   Sheng, Li ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin; Atrial fibrillation; Remodeling

Indexed keywords

CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIAL EFFECTIVE REFRACTORY PERIOD; BLOOD FLOW VELOCITY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; DRUG EFFECT; DRUG EFFICACY; ELECTRODE; EPICARDIUM; FEMALE; HEART ATRIUM CONDUCTION; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART EJECTION FRACTION; HEART LEFT ATRIUM; HEART MUSCLE FIBROSIS; HEART MUSCLE REFRACTORY PERIOD; HEART VOLUME; IMAGE ANALYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 33845656100     PISSN: 00220736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jelectrocard.2006.04.001     Document Type: Article

References (23)

1. Dai Y., Wang X., Cao L., et al. Expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Huazhong Univ Sci Technolog Med Sci 24 (2004) 32
2. Nakashima H., Kumagai K., Urata H., et al. Angiotensin II antagonist prevents electrical remolding in atrial fibrillation. Circulation 101 (2000) 2612
3. Pedersen O.D., Bagger H., Kober L., et al. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 100 (1999) 376
4. Hirayama Y., Atarashi H., Kobayashi Y., et al. Angiotensin-converting enzyme inhibitor therapy inhibits the progression from paroxysmal atrial fibrillation to chronic atrial fibrillation. Circ J 69 (2005) 671
5. Madrid A.H., Marin I.M., Cervantes C.E., et al. Prevention of recurrences in patients with lone atrial fibrillation. The dose-dependent effect of angiotensin II receptor blockers. J Renin Angiotensin Aldosterone Sys 5 (2004) 114
6. Kinebuchi O., Mitamura H., Shiroshita-Takeshita A., et al. Oral verapamil attenuates the progression of pacing-induced electrical and mechanical remodeling of the atrium. Circ J 68 (2004) 494
7. Kurita Y., Mitamura H., Shiroshita-Takeshita A., et al. Daily oral verapamil before but not after rapid atrial excitation prevents electrical remodeling. Cardiovasc Res 54 (2002) 447
8. Gassanov N., Brandt M.C., Michels G., et al. Angiotensin II-induced changes of calcium sparks and ionic currents in human atrial myocytes: potential role for early remodeling in atrial fibrillation. Cell Calcium 39 (2006) 175
9. Touyz R.M., Sventek P., Lariviere R., et al. Cytosolic calcium changes induced by angiotensin II in neonatal rat atrial and ventricular cardiomyocytes are mediated via angiotensin II subtype 1 receptors. Hypertension 27 (1996) 1090
10. Willems R., Sipido K.R., Holemans P., et al. Different patterns of angiotensin II and atrial natriuretic peptide secretion in a sheep model of atrial fibrillation. J Cardiovasc Electrophysiol 12 (2001) 1387
11. Sonoyama K., Igawa O., Miake J., et al. Effects of angiotensin II on the action potential durations of atrial myocytes in hypertensive rats. Hypertens Res 28 (2005) 173
12. + channels in porcine endocardial endothelium. Proc Natl Acad Sci U S A 91 (1994) 2367
13. Zarse M., Stellbrink C., Athanatou E., et al. Verapamil prevents stretch-induced shortening of atrial effective refractory period in Langendorff-perfused rabbit heart. J Cardiovasc Electrophysiol 12 (2001) 85
14. Li Y., Li W.M., Xue J.Y., et al. Effects of losartan on acute atrial electrical remodeling. Chin Med J 117 (2004) 643
15. Shinagawa K., Mitamura H., Ogawa S., et al. Effects of inhibiting Na(+)/H(+)-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling. Cardiovasc Res 54 (2002) 438
16. Kumagai K., Nakashima H., Urata H., et al. Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Coll Cardiol 41 (2003) 2197
17. Soylu M., Demir A.D., Ozdemir O., et al. Evaluation of atrial refractoriness immediately after percutaneous mitral balloon commissurotomy in patients with mitral stenosis and sinus rhythm. Am Heart J 147 (2004) 741
18. Li D., Fareh S., Leung T.K., et al. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 100 (1999) 87
19. Eijsbouts S.C., Majidi M., van Zandvoort M., et al. Effects of acute atrial dilation on heterogeneity in conduction in the isolated rabbit heart. J Cardiovasc Electrophysiol 14 (2003) 269
20. Fuenmayor A.J., Moreno G., Landaeta A., et al. Inter-atrial conduction time shortens after blood pressure control in hypertensive patients with left ventricular hypertrophy. Int J Cardiol 102 (2005) 443
21. Li D., Shinagawa K., Pang L., et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 104 (2001) 2608
22. Shi Y., Ducharme A., Li D., et al. Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation. Cardiovasc Res 52 (2001) 217
23. Xiao H.D., Fuchs S., Campbell D.J., et al. Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. Am J Pathol 165 (2004) 1019